Skip to main content
Premium Trial:

Request an Annual Quote

Promega, SignalChem Team on Kinase Profiling Tools

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Promega today announced that it has partnered with SignalChem Pharmaceuticals to offer a combination of their technologies for profiling kinase inhibitors against the human kinome.

The offering will combine SignalChem's Kinase Enzyme Systems with Promega's ADP-Glo Kinase Assay. Madison, Wis.-based Promega said that the combination provides "all of the necessary tools and give[s] drug screeners unprecedented ease to profile inhibitors against the human kinome for off-target effects."

Promega said that its will distribute SignalChem's Kinase Enzyme Systems as a stand-alone enzyme system or in combination with its own ADP-Glo Assay.

Further terms of the alliance were not disclosed.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.